BlossomHill Therapeutics, a biotech company focused on the field of oncology, plans to raise approximately $132.8 million through an initial public offering.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.